Global Innovative Platforms (GIPL) Consolidated Net Income (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Consolidated Net Income came in at -$241611.0 in Q2 2026, down 14.07% year-over-year from -$281156.8 in Q2 2025, and down 59.6% quarter-over-quarter from -$151386.0 in Q1 2026.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Consolidated Net Income (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Consolidated Net Income across 7 years of filings, most recently posting -$241611.0 for Q2 2026.
- In Q2 2026, Consolidated Net Income fell 14.07% year-over-year to -$241611.0; the TTM figure through Jun 2026 stood at -$677042.0 (down 20.87% YoY), while the FY2025 annual figure was -$718251.0, down 427.36% from the prior year.
- Consolidated Net Income came in at -$241611.0 for Q2 2026 at Global Innovative Platforms, down from -$151386.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$2650.0 in Q2 2023 to a low of -$241611.0 in Q2 2026.
- Average Consolidated Net Income over 5 years is -$90386.6, with a median of -$72676.0 recorded in 2023.
- Year-over-year, Consolidated Net Income surged 94.36% in 2024 and tumbled 3793.77% in 2025.
- Over 5 years, Consolidated Net Income stood at -$87166.0 in 2022, then surged by 43.25% to -$49469.0 in 2023, then tumbled by 143.52% to -$120467.0 in 2024, then soared by 58.97% to -$49429.0 in 2025, then tumbled by 388.8% to -$241611.0 in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were -$241611.0 in Q2 2026, -$151386.0 in Q1 2026, and -$49429.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 338.41 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 866.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 54.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 21.71 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 1.83 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -241,611.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -241,611.00 |
| Mar 31, 2026 | -151,386.00 |
| Dec 31, 2025 | -49,429.00 |
| Sep 30, 2025 | -234,616.00 |
| Jun 30, 2025 | -211,818.00 |
| Mar 31, 2025 | -151,351.00 |
| Dec 31, 2024 | -120,467.00 |
| Sep 30, 2024 | -76,482.00 |
| Jun 30, 2024 | -6,360.00 |
| Mar 31, 2024 | -3,887.00 |
| Dec 31, 2023 | -49,469.00 |
| Sep 30, 2023 | -124,100.00 |
| Jun 30, 2023 | -2,650.00 |
| Mar 31, 2023 | -68,870.00 |
| Dec 31, 2022 | -87,166.00 |
| Sep 30, 2022 | -35,604.00 |
| Jun 30, 2022 | -6,609.00 |
| Mar 31, 2022 | -5,083.00 |
| Dec 31, 2021 | -6,520.00 |
| Sep 30, 2021 | -21,677.00 |